Since all the CTAs and import licenses of all Onco studies have been transferred to NVS since the beginning of 2016. In this case, GSK Thailand has no involvement in any payment to HCPs/HCOs relevant to the studies.
NVS is now doing the payment by their own.
Does it answer to your request? If there is any question, pls let me know.